April 4, 2013

Gil Amelio and Rod D. Martin interviewed by Dennis Kneale of MarketsNow on Fox Business, on the emerging biotechnology sector in Atlanta, Georgia. They discuss the advantages in Atlanta, exciting breakthroughs toward a cure for fatty liver disease happening now, and how the best in biotechnology is centering on Atlanta, right now.


Gil Amelio is the former CEO of Apple Computer and a director of AT&T, a member of Galectin Therapeutics’ board of directors and former director of Chiron. He received his B.S., M.A., & Ph.D. in physics from Georgia Tech. He is a cancer survivor.

Rod Martin, CEO of The Martin Organization, is Vice Chairman of Galectin Therapeutics, was a senior member of PayPal.com’s pre-IPO startup team, former policy director to Governor Mike Huckabee, and President of the National Federation of Republican Assemblies.  He is online at RodMartin.org.


Editor’s Note: This interview with Gil Amelio and Rod D. Martin was recorded on April 4, 2013 at the New York City Bureau of FoxNews. It aired live at 12:30 p.m. on FoxBusiness.com.